Caspase-9 inhibition triggers Hsp90-based chemotherapy-mediated tumor intrinsic innate sensing and enhances antitumor immunity
Jingyang Li, Xiaoyu Han, Mayu Sun, Weida Li, Guanghuan Yang, Huiyi Chen, Bao Guo, Jingquan Li, Xiaoguang Li, Hui Wang · 2023
Read Caspase-9 inhibition triggers Hsp90-based chemotherapy-mediated tumor intrinsic innate sensing and enhances antitumor immunity by Jingyang Li, Xiaoyu Han, Mayu Sun, Weida Li, Guanghuan Yang, Huiyi Chen, Bao Guo, Jingquan Li, Xiaoguang Li, Hui Wang (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10711858.txt.
Description
Jingyang Li and co-authors found a way to make chemo provoke a stronger immune attack on tumors, in this 2023 study. Chemo works best when dying tumor cells alert the immune system. Yet the very enzymes that kill the cells also mute that alert.
A drug screen pointed to a heat-shock protein blocker that kills tumor cells but hides their DNA alarm. Blocking one death enzyme, caspase-9, freed the alarm without sparing the cells. The combo released immune signals and shrank tumors in mice. Tumors fought back by raising a brake protein, and blocking that brake as well led to full tumor clearance in the models.
Catalog record
| CREATOR | Jingyang Li, Xiaoyu Han, Mayu Sun, Weida Li, Guanghuan Yang, Huiyi Chen, Bao Guo, Jingquan Li, Xiaoguang Li, Hui Wang |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |